HEADER    LIPID BINDING PROTEIN                   07-MAR-14   2MM3              
TITLE     SOLUTION NMR STRUCTURE OF THE TERNARY COMPLEX OF HUMAN ILEAL BILE     
TITLE    2 ACID-BINDING PROTEIN WITH GLYCOCHOLATE AND GLYCOCHENODEOXYCHOLATE    
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: GASTROTROPIN;                                              
COMPND   3 CHAIN: A;                                                            
COMPND   4 SYNONYM: ILEAL LIPID-BINDING PROTEIN;                                
COMPND   5 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 ORGANISM_TAXID: 9606;                                                
SOURCE   5 GENE: FABP6;                                                         
SOURCE   6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   7 EXPRESSION_SYSTEM_TAXID: 562;                                        
SOURCE   8 EXPRESSION_SYSTEM_VECTOR_TYPE: VECTOR;                               
SOURCE   9 EXPRESSION_SYSTEM_VECTOR: PMON5840                                   
KEYWDS    LIPID-BINDING PROTEIN, ORTHOGONAL BETA SHEETS, POSITIVE BINDING       
KEYWDS   2 COOPERATIVITY, SITE-SELECTIVITY, ENTEROHEPATIC CIRCULATION, LIPID    
KEYWDS   3 BINDING PROTEIN                                                      
EXPDTA    SOLUTION NMR                                                          
NUMMDL    10                                                                    
AUTHOR    G.HORVATH,O.EGYED,A.BENCSURA,A.SIMON,G.P.TOCHTROP,G.T.DEKOSTER,       
AUTHOR   2 D.F.COVEY,D.P.CISTOLA,O.TOKE                                         
REVDAT   5   15-MAY-24 2MM3    1       REMARK                                   
REVDAT   4   14-JUN-23 2MM3    1       REMARK                                   
REVDAT   3   17-OCT-18 2MM3    1       JRNL                                     
REVDAT   2   30-DEC-15 2MM3    1       JRNL                                     
REVDAT   1   07-MAY-14 2MM3    0                                                
JRNL        AUTH   G.HORVATH,A.BENCSURA,A.SIMON,G.P.TOCHTROP,G.T.DEKOSTER,      
JRNL        AUTH 2 D.F.COVEY,D.P.CISTOLA,O.TOKE                                 
JRNL        TITL   STRUCTURAL DETERMINANTS OF LIGAND BINDING IN THE TERNARY     
JRNL        TITL 2 COMPLEX OF HUMAN ILEAL BILE ACID BINDING PROTEIN WITH        
JRNL        TITL 3 GLYCOCHOLATE AND GLYCOCHENODEOXYCHOLATE OBTAINED FROM        
JRNL        TITL 4 SOLUTION NMR                                                 
JRNL        REF    FEBS J.                       V. 283   541 2016              
JRNL        REFN                   ISSN 1742-4658                               
JRNL        PMID   26613247                                                     
JRNL        DOI    10.1111/FEBS.13610                                           
REMARK   1                                                                      
REMARK   1 REFERENCE 1                                                          
REMARK   1  AUTH   O.TOKE,J.D.MONSEY,G.T.DEKOSTER,G.P.TOCHTROP,C.TANG,          
REMARK   1  AUTH 2 D.P.CISTOLA                                                  
REMARK   1  TITL   DETERMINANTS OF COOPERATIVITY AND SITE SELECTIVITY IN HUMAN  
REMARK   1  TITL 2 ILEAL BILE ACID BINDING PROTEIN.                             
REMARK   1  REF    BIOCHEMISTRY                  V.  45   727 2006              
REMARK   1  REFN                   ISSN 0006-2960                               
REMARK   1  PMID   16411748                                                     
REMARK   1  DOI    10.1021/BI051781P                                            
REMARK   1 REFERENCE 2                                                          
REMARK   1  AUTH   G.P.TOCHTROP,G.T.DEKOSTER,D.F.COVEY,D.P.CISTOLA              
REMARK   1  TITL   A SINGLE HYDROXYL GROUP GOVERNS LIGAND SITE SELECTIVITY IN   
REMARK   1  TITL 2 HUMAN ILEAL BILE ACID BINDING PROTEIN.                       
REMARK   1  REF    J.AM.CHEM.SOC.                V. 126 11024 2004              
REMARK   1  REFN                   ISSN 0002-7863                               
REMARK   1  PMID   15339188                                                     
REMARK   1  DOI    10.1021/JA047589C                                            
REMARK   1 REFERENCE 3                                                          
REMARK   1  AUTH   O.TOKE,J.D.MONSEY,D.P.CISTOLA                                
REMARK   1  TITL   KINETIC MECHANISM OF LIGAND BINDING IN HUMAN ILEAL BILE ACID 
REMARK   1  TITL 2 BINDING PROTEIN AS DETERMINED BY STOPPED-FLOW FLUORESCENCE   
REMARK   1  TITL 3 ANALYSIS.                                                    
REMARK   1  REF    BIOCHEMISTRY                  V.  46  5427 2007              
REMARK   1  REFN                   ISSN 0006-2960                               
REMARK   1  PMID   17432832                                                     
REMARK   1  DOI    10.1021/BI700030R                                            
REMARK   1 REFERENCE 4                                                          
REMARK   1  AUTH   G.HORVATH,P.KIRALY,G.TARKANYI,O.TOKE                         
REMARK   1  TITL   INTERNAL MOTIONS AND EXCHANGE PROCESSES IN HUMAN ILEAL BILE  
REMARK   1  TITL 2 ACID BINDING PROTEIN AS STUDIED BY BACKBONE (15)N NUCLEAR    
REMARK   1  TITL 3 MAGNETIC RESONANCE SPECTROSCOPY.                             
REMARK   1  REF    BIOCHEMISTRY                  V.  51  1848 2012              
REMARK   1  REFN                   ISSN 0006-2960                               
REMARK   1  PMID   22329738                                                     
REMARK   1  DOI    10.1021/BI201588Q                                            
REMARK   1 REFERENCE 5                                                          
REMARK   1  AUTH   G.HORVATH,P.KIRALY,G.TARKANYI,O.TOKE                         
REMARK   1  TITL   INTERNAL MOTIONS AND EXCHANGE PROCESSES IN HUMAN ILEAL BILE  
REMARK   1  TITL 2 ACID BINDING PROTEIN AS STUDIED BY BACKBONE (15)N NUCLEAR    
REMARK   1  TITL 3 MAGNETIC RESONANCE SPECTROSCOPY                              
REMARK   1  REF    BIOCHEMISTRY                  V.  51  1848 2012              
REMARK   1  REFN                   ISSN 0006-2960                               
REMARK   2                                                                      
REMARK   2 RESOLUTION. NOT APPLICABLE.                                          
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : VNMRJ, ARIA 2.1                                      
REMARK   3   AUTHORS     : VARIAN (VNMRJ), LINGE, O'DONOGHUE AND NILGES         
REMARK   3                 (ARIA)                                               
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 2MM3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 18-MAR-14.                  
REMARK 100 THE DEPOSITION ID IS D_1000103776.                                   
REMARK 210                                                                      
REMARK 210 EXPERIMENTAL DETAILS                                                 
REMARK 210  EXPERIMENT TYPE                : NMR                                
REMARK 210  TEMPERATURE           (KELVIN) : 293                                
REMARK 210  PH                             : 6.3                                
REMARK 210  IONIC STRENGTH                 : 70                                 
REMARK 210  PRESSURE                       : AMBIENT                            
REMARK 210  SAMPLE CONTENTS                : 1.0 MM [U-13C; U-15N] HUMAN        
REMARK 210                                   ILEAL BILE ACID-BINDING PROTEIN-   
REMARK 210                                   1, 1.5 MM GLYCOCHOLIC ACID-2,      
REMARK 210                                   1.5 MM GLYCOCHENODEOXYCHOLIC       
REMARK 210                                   ACID-3, 20 MM POTASSIUM            
REMARK 210                                   PHOSPHATE-4, 50 MM POTASSIUM       
REMARK 210                                   CHLORIDE-5, 0.05 % SODIUM AZIDE-   
REMARK 210                                   6, 90% H2O/10% D2O; 1.0 MM HUMAN   
REMARK 210                                   ILEAL BILE ACID-BINDING PROTEIN-   
REMARK 210                                   7, 1.5 MM [U-15N] GLYCOCHOLIC      
REMARK 210                                   ACID-8, 1.5 MM [U-15N]             
REMARK 210                                   GLYCOCHENODEOXYCHOLIC ACID-9, 20   
REMARK 210                                   MM POTASSIUM PHOSPHATE-10, 50 MM   
REMARK 210                                   POTASSIUM CHLORIDE-11, 0.05 %      
REMARK 210                                   SODIUM AZIDE-12, 90% H2O/10% D2O;  
REMARK 210                                   1.0 MM HUMAN ILEAL BILE ACID-      
REMARK 210                                   BINDING PROTEIN-13, 1.5 MM 1',2'-  
REMARK 210                                   13C GLYCOCHOLIC ACID-14, 1.5 MM    
REMARK 210                                   1',2'-13C GLYCOCHENODEOXYCHOLIC    
REMARK 210                                   ACID-15, 20 MM POTASSIUM           
REMARK 210                                   PHOSPHATE-16, 50 MM POTASSIUM      
REMARK 210                                   CHLORIDE-17, 0.05 % SODIUM AZIDE-  
REMARK 210                                   18, 90% H2O/10% D2O; 1.0 MM        
REMARK 210                                   HUMAN ILEAL BILE ACID-BINDING      
REMARK 210                                   PROTEIN-19, 1.5 MM 3,4-13C         
REMARK 210                                   GLYCOCHOLIC ACID-20, 1.5 MM 3,4-   
REMARK 210                                   13C GLYCOCHENODEOXYCHOLIC ACID-    
REMARK 210                                   21, 20 MM POTASSIUM PHOSPHATE-22,  
REMARK 210                                   50 MM POTASSIUM CHLORIDE-23,       
REMARK 210                                   0.05 % SODIUM AZIDE-24, 90% H2O/   
REMARK 210                                   10% D2O; 1.0 MM HUMAN ILEAL BILE   
REMARK 210                                   ACID-BINDING PROTEIN-25, 1.5 MM    
REMARK 210                                   23,24-13C GLYCOCHOLIC ACID-26,     
REMARK 210                                   1.5 MM 23,24-13C                   
REMARK 210                                   GLYCOCHENODEOXYCHOLIC ACID-27,     
REMARK 210                                   20 MM POTASSIUM PHOSPHATE-28, 50   
REMARK 210                                   MM POTASSIUM CHLORIDE-29, 0.05 %   
REMARK 210                                   SODIUM AZIDE-30, 90% H2O/10% D2O   
REMARK 210                                                                      
REMARK 210  NMR EXPERIMENTS CONDUCTED      : 2D 1H-15N HSQC; 3D HNCACB; 3D      
REMARK 210                                   CBCA(CO)NH; 3D HNCO; CBCACOCAHA;   
REMARK 210                                   HN(CO)CA; 3D CC-TOCSY-NNH; 3D      
REMARK 210                                   HCC-TOCSY; 3D HCCH-TOCSY; 2D       
REMARK 210                                   CG(CB)HB; 2D CG(CD)HD; 2D          
REMARK 210                                   CG(CDCE)HE; 2D 1H-13C HSQC         
REMARK 210                                   ALIPHATIC; 2D 1H-13C HSQC          
REMARK 210                                   AROMATIC; 3D 1H-15N NOESY; 3D 1H-  
REMARK 210                                   13C NOESY ALIPHATIC; 3D 1H-13C     
REMARK 210                                   NOESY AROMATIC; 3D NH-NH NOESY;    
REMARK 210                                   3D MET-MET NOESY; 2D 15N-EDITED    
REMARK 210                                   NOESY; 2D 13C-EDITED NOESY         
REMARK 210  SPECTROMETER FIELD STRENGTH    : 600 MHZ                            
REMARK 210  SPECTROMETER MODEL             : VARIAN NMR SYSTEM                  
REMARK 210  SPECTROMETER MANUFACTURER      : VARIAN                             
REMARK 210                                                                      
REMARK 210  STRUCTURE DETERMINATION.                                            
REMARK 210   SOFTWARE USED                 : FELIX, ARIA 2.1                    
REMARK 210   METHOD USED                   : SIMULATED ANNEALING, TORSION       
REMARK 210                                   ANGLE DYNAMICS                     
REMARK 210                                                                      
REMARK 210 CONFORMERS, NUMBER CALCULATED   : 100                                
REMARK 210 CONFORMERS, NUMBER SUBMITTED    : 10                                 
REMARK 210 CONFORMERS, SELECTION CRITERIA  : STRUCTURES WITH THE LOWEST         
REMARK 210                                   ENERGY                             
REMARK 210                                                                      
REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1                   
REMARK 210                                                                      
REMARK 210 REMARK: NULL                                                         
REMARK 215                                                                      
REMARK 215 NMR STUDY                                                            
REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION           
REMARK 215 NMR DATA.  PROTEIN DATA BANK CONVENTIONS REQUIRE THAT                
REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON              
REMARK 215 THESE RECORDS ARE MEANINGLESS.                                       
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500  1 GLU A   9       67.10   -157.48                                   
REMARK 500  1 SER A  10      126.77   -177.83                                   
REMARK 500  1 SER A  25      -16.51   -156.55                                   
REMARK 500  1 LYS A  35      106.17     51.37                                   
REMARK 500  1 ILE A  36      150.96    -34.21                                   
REMARK 500  1 SER A  54      -51.94    -23.72                                   
REMARK 500  1 LEU A 126       41.34   -150.86                                   
REMARK 500  2 GLU A  11       46.61   -173.52                                   
REMARK 500  2 SER A  25      -22.03   -155.88                                   
REMARK 500  2 LYS A  35      160.99     65.20                                   
REMARK 500  2 SER A  54     -123.75     37.58                                   
REMARK 500  2 LEU A 126       22.68   -149.05                                   
REMARK 500  3 SER A  10       90.89   -168.37                                   
REMARK 500  3 ASN A  13       19.14     55.67                                   
REMARK 500  3 SER A  25      -24.86   -146.84                                   
REMARK 500  3 ASN A  33      -84.91   -105.15                                   
REMARK 500  3 LYS A  35      127.28     64.65                                   
REMARK 500  3 SER A  54       28.15     49.61                                   
REMARK 500  3 GLU A 120       72.86   -157.90                                   
REMARK 500  3 LEU A 126       17.21   -157.97                                   
REMARK 500  4 THR A   3      144.64    -29.52                                   
REMARK 500  4 SER A  25      -32.72   -146.26                                   
REMARK 500  4 PHE A  34       -8.50   -140.90                                   
REMARK 500  4 LYS A  35      132.92     68.07                                   
REMARK 500  4 TYR A  53       65.54    -63.88                                   
REMARK 500  4 SER A  54        8.33     59.22                                   
REMARK 500  4 HIS A  57      123.00   -170.35                                   
REMARK 500  4 MET A  74        7.38    -63.57                                   
REMARK 500  4 THR A 100      118.91   -167.54                                   
REMARK 500  4 LEU A 126       25.46   -156.99                                   
REMARK 500  5 THR A   3      139.18    -24.19                                   
REMARK 500  5 SER A  10      105.12   -168.31                                   
REMARK 500  5 LYS A  12       76.07   -158.17                                   
REMARK 500  5 SER A  25      -34.47   -132.37                                   
REMARK 500  5 ASP A  26      -76.49    -35.37                                   
REMARK 500  5 PHE A  34      -90.58   -110.81                                   
REMARK 500  5 LYS A  35      177.28    170.77                                   
REMARK 500  5 HIS A  57      143.59    171.54                                   
REMARK 500  5 MET A  85       62.22   -117.09                                   
REMARK 500  5 GLU A  86       96.19    -68.94                                   
REMARK 500  5 LEU A 126        9.78   -150.37                                   
REMARK 500  6 GLU A   9       69.40   -160.71                                   
REMARK 500  6 SER A  10      107.82   -167.41                                   
REMARK 500  6 ASN A  13       26.31     93.82                                   
REMARK 500  6 SER A  25      -33.18   -152.87                                   
REMARK 500  6 LYS A  35      125.81     56.98                                   
REMARK 500  6 ASN A  70       21.67   -152.55                                   
REMARK 500  6 THR A 100      115.70   -162.20                                   
REMARK 500  6 LEU A 126      -10.97   -154.35                                   
REMARK 500  7 THR A   3      135.33    -35.92                                   
REMARK 500                                                                      
REMARK 500 THIS ENTRY HAS      77 RAMACHANDRAN OUTLIERS.                        
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GCH A 201                 
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC2                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CHO A 202                 
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 19843   RELATED DB: BMRB                                 
DBREF  2MM3 A    1   127  UNP    P51161   FABP6_HUMAN      2    128             
SEQRES   1 A  127  ALA PHE THR GLY LYS PHE GLU MET GLU SER GLU LYS ASN          
SEQRES   2 A  127  TYR ASP GLU PHE MET LYS LEU LEU GLY ILE SER SER ASP          
SEQRES   3 A  127  VAL ILE GLU LYS ALA ARG ASN PHE LYS ILE VAL THR GLU          
SEQRES   4 A  127  VAL GLN GLN ASP GLY GLN ASP PHE THR TRP SER GLN HIS          
SEQRES   5 A  127  TYR SER GLY GLY HIS THR MET THR ASN LYS PHE THR VAL          
SEQRES   6 A  127  GLY LYS GLU SER ASN ILE GLN THR MET GLY GLY LYS THR          
SEQRES   7 A  127  PHE LYS ALA THR VAL GLN MET GLU GLY GLY LYS LEU VAL          
SEQRES   8 A  127  VAL ASN PHE PRO ASN TYR HIS GLN THR SER GLU ILE VAL          
SEQRES   9 A  127  GLY ASP LYS LEU VAL GLU VAL SER THR ILE GLY GLY VAL          
SEQRES  10 A  127  THR TYR GLU ARG VAL SER LYS ARG LEU ALA                      
HET    GCH  A 201      75                                                       
HET    CHO  A 202      74                                                       
HETNAM     GCH GLYCOCHOLIC ACID                                                 
HETNAM     CHO GLYCOCHENODEOXYCHOLIC ACID                                       
HETSYN     GCH N-CHOLYLGLYCINE                                                  
FORMUL   2  GCH    C26 H43 N O6                                                 
FORMUL   3  CHO    C26 H43 N O5                                                 
HELIX    1   1 ASN A   13  GLY A   22  1                                  10    
HELIX    2   2 SER A   25  LYS A   35  1                                  11    
SHEET    1   A 7 HIS A  57  THR A  64  0                                        
SHEET    2   A 7 ASP A  46  TYR A  53 -1  N  GLN A  51   O  MET A  59           
SHEET    3   A 7 VAL A  37  ASP A  43 -1  N  GLN A  41   O  THR A  48           
SHEET    4   A 7 GLY A   4  LYS A  12 -1  N  GLY A   4   O  VAL A  40           
SHEET    5   A 7 VAL A 117  ARG A 125 -1  O  LYS A 124   N  GLU A   7           
SHEET    6   A 7 LYS A 107  ILE A 114 -1  N  SER A 112   O  TYR A 119           
SHEET    7   A 7 TYR A  97  VAL A 104 -1  N  VAL A 104   O  LYS A 107           
SHEET    1   B 2 ILE A  71  GLN A  72  0                                        
SHEET    2   B 2 THR A  78  PHE A  79 -1  O  PHE A  79   N  ILE A  71           
SHEET    1   C 2 GLN A  84  MET A  85  0                                        
SHEET    2   C 2 LEU A  90  VAL A  91 -1  O  VAL A  91   N  GLN A  84           
SITE     1 AC1 22 PHE A   2  PHE A   6  MET A   8  MET A  18                    
SITE     2 AC1 22 ALA A  31  ILE A  36  THR A  38  VAL A  40                    
SITE     3 AC1 22 PHE A  47  TRP A  49  GLN A  51  MET A  74                    
SITE     4 AC1 22 LEU A  90  SER A 101  GLU A 102  LEU A 108                    
SITE     5 AC1 22 VAL A 109  GLU A 110  TYR A 119  ARG A 121                    
SITE     6 AC1 22 SER A 123  CHO A 202                                          
SITE     1 AC2 17 LEU A  21  ILE A  23  TRP A  49  ASN A  61                    
SITE     2 AC2 17 PHE A  63  GLN A  72  THR A  73  MET A  74                    
SITE     3 AC2 17 GLY A  75  LYS A  77  PHE A  79  VAL A  83                    
SITE     4 AC2 17 LEU A  90  VAL A  92  TYR A  97  GLN A  99                    
SITE     5 AC2 17 GCH A 201                                                     
CRYST1    1.000    1.000    1.000  90.00  90.00  90.00 P 1           1          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      1.000000  0.000000  0.000000        0.00000                         
SCALE2      0.000000  1.000000  0.000000        0.00000                         
SCALE3      0.000000  0.000000  1.000000        0.00000                         
MODEL        1